Biocartis Group NV Logo

Biocartis Group NV

BCART | BR

Overview

Corporate Details

ISIN(s):
BE0974281132 (+1 more)
LEI:
549300J4HOJL5KG8HY54
Country:
Belgium
Address:
GENERAAL DE WITTELAAN 11 BOÎTE B, 2800 MECHELEN
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Biocartis Group NV is an innovative molecular diagnostics company committed to revolutionizing molecular testing. The company develops and commercializes its unique, proprietary Idylla™ platform, a fully automated, real-time PCR-based system designed to provide fast, easy, and actionable molecular diagnostic results. Biocartis' mission is to enable personalized medicine and improve patient outcomes by making molecular testing accessible to any lab, regardless of size or expertise. The company's primary focus is on providing tests for oncology and infectious diseases.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Biocartis Group NV. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-01-10 00:00
Major Shareholding Notification
BIOCARTIS GROUP NV 2024-01-05 to Issuer (JPM).pdf
English 219.7 KB
2024-01-10 00:00
Major Shareholding Notification
20240110_Share treshold notification_JPM_ENG.pdf
English 103.6 KB
2023-10-03 07:00
Declaration of Voting Results & Voting Rights Announcements
JJDC - Biocartis - Transparency Notification Form - Final - 27 September 2023 -…
English 514.6 KB
2023-10-03 07:00
Major Shareholding Notification
20231003_PR TranspNotification_JJDC_ENG.pdf
English 73.0 KB
2023-10-03 07:00
Major Shareholding Notification
20231003_PR TranspNotification_JJDC_NL.pdf
Dutch 74.8 KB
2023-09-26 07:00
Interim Report
MASTER Biocartis H1 2023 Financial Report ENG_FINAL.pdf
English 8.2 MB
2023-09-26 07:00
Interim Report
Biocartis H1 2023 Financial Report NLD_FINAL.pdf
Dutch 9.5 MB
2023-09-26 07:00
Earnings Release
20230926 PR H1 2023 Results_ENG.pdf
English 203.5 KB
2023-09-26 07:00
Earnings Release
20230926 PR H1 2023 Results_NL.pdf
Dutch 204.9 KB
2023-07-18 07:00
Board/Management Information
20230718_cfo_announcement_eng.pdf
English 112.3 KB
2023-07-18 07:00
Board/Management Information
20230718_cfo_announcement_nl.pdf
Dutch 75.5 KB
2023-06-30 07:00
Declaration of Voting Results & Voting Rights Announcements
pr_outstanding_shares_june2023_eng.pdf
English 109.9 KB
2023-06-30 07:00
Declaration of Voting Results & Voting Rights Announcements
pr_outstanding_shares_june2023_nl_1.pdf
Dutch 114.9 KB
2023-06-20 17:40
Declaration of Voting Results & Voting Rights Announcements
230619_pr_transpnotification_ubs_eng.pdf
English 74.9 KB
2023-06-20 17:40
Declaration of Voting Results & Voting Rights Announcements
230619_pr_transpnotification_ubs_nl.pdf
Dutch 93.3 KB

Automate Your Workflow. Get a real-time feed of all Biocartis Group NV filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Biocartis Group NV via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-04-29 Devogelaere Benoit Executive member Buy 15,000 N/A
2021-04-28 Marcofin BV Executive member Buy 30,000 N/A
2021-04-27 Herman Verrelst Board Buy 60,000 N/A
2020-11-13 Devogelaere Benoit Executive member Buy 50,000 N/A
2020-05-06 Herman Verrelst Board Buy 50,000 249,625.00 EUR
2020-05-06 Herman Verrelst Board Buy 300,000 N/A
2020-05-04 Herman Verrelst Board Buy 46,803 231,656.00 EUR
2020-05-04 Herman Verrelst Board Buy 3,197 15,315.00 EUR
2019-12-18 Devogelaere Benoit Executive member Buy 50,000 N/A
2019-12-16 Welten Ewoud Executive member Buy 10,000 N/A

Peer Companies

Company Country Ticker View
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
Affluent Medical Logo
Develops adjustable, minimally invasive implants for structural heart disease and urology.
France AFME
Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland AWM
Alcon AG Logo
A global leader in eye care, offering surgical and vision care products worldwide.
Switzerland ALC
Allmed Solutions Ltd. Logo
Develops and markets advanced, minimally invasive medical products for healthcare professionals globally.
Israel ALMD
Alteco Medical AB Logo
Develops blood purification devices to remove endotoxins from patients with sepsis in intensive care.
Sweden ALTE
Ambu Logo
Develops single-use endoscopes, anaesthesia, and monitoring devices to improve patient safety.
Denmark AMBU
Amplitude Surgical Logo
Develops and markets high-end orthopedic implants for hip and knee pathologies worldwide.
France AMPLI